The Food and Drug Administration is days away from giving its full approval to one of the COVID-19 vaccines.

The vote for the Pfizer vaccine is expected to happen as early as Monday, according to a report from the New York Times.

The move would make it the first COVID-19 shot to go from an emergency use authorization to full approval.

The biotech company began applying for full authorization in May after getting emergency approval last December.

More than 200 million Pfizer doses have been given out nationwide, fully vaccinating around 90-million Americans, according to data from the Centers for Disease Control and Prevention.

The decision could also lead to more vaccine mandates and possibly push the remaining vaccine-hesitant people to get the shot.

Judith Watson, who is the CEO of the nonprofit organization Mount Vernon Neighborhood Health Center, has been on the frontlines of helping people who are vaccine-hesitant to get the shot.

She says, “We'll use it as a means to an end so it will be one more tool in our toolbox of convincing folks of why they need to get vaccinated."

Local health officials say Mount Vernon has a vaccination rate of 52%, which is the lowest in Westchester County.

This vote also comes at another critical time. In just a few weeks millions of fully vaccinated Americans will become eligible for a COVID-19 booster shot.